application): The Outreach Core provides the vehicle through which the multidisciplinary D&E Team conducts research and training beyond the MDU. Thus, the Outreach Core allows the DRTC to develop and evaluate programs in """"""""real world"""""""" settings - settings likely to have more barriers to the delivery of diabetes care than are found in the artificially ideal setting of the MDU. The Outreach Core was established in 1990 with Dr. Judith Wylie-Rosett as Director and Dr. Elizabeth Walker as Associate Director. They continue to provide the Core leadership. The first objective of the Outreach Core is to identify and address barriers to the routine practice of """"""""ideal care reflecting current scientific advances in the understanding of diabetes"""""""". The special focus of the D&E on underserved populations is designed to address current gaps in health care delivery to high risk groups. The second objective of the Outreach Core is to develop and implement interventions that have maximal potential for effectiveness in the real world. Intervention development is guided by the Precede-Proceed model of health promotion planning and focuses sharply on discrete health behaviors selected for their importance and changeability. The third objective of the Outreach Core is to establish liaisons with other organizations. Liaisons work to expand, and so strengthen our team, and to open up new arenas for the assessment of D&E training and intervention programs. The fourth objective of the Outreach Core is to serve as a national resource for information related to programmatic goals by making exemplary material available to the clinical community. The two main avenues of dissemination are through consultation and manuscripts or presentations. The last objective of the Outreach Core is to identify, recruit and enroll suitable target populations so that D&E training and intervention programs can be evaluated in real world conditions. The Outreach Core tries to balance the need to find health care settings which run smoothly enough to make successful implementation of programs feasible, while still retaining a focus on underserved populations. Once a site has been chosen, the Outreach Core and the Evaluation Core work together to monitor recruitment and retention.

Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Liu, Shunmei; Marcelin, Genevieve; Blouet, Clemence et al. (2018) A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus. Mol Metab 8:37-50
Llewellyn, Sean R; Britton, Graham J; Contijoch, Eduardo J et al. (2018) Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice. Gastroenterology 154:1037-1046.e2
Rudolph, Bryan; Bjorklund, Nicole; Ovchinsky, Nadia et al. (2018) Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design. Contemp Clin Trials 75:51-58
Tang, Yan; Kwon, Hyokjoon; Neel, Brian A et al. (2018) The fructose-2,6-bisphosphatase TIGAR suppresses NF-?B signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC. J Biol Chem 293:7578-7591
Chemaly, Elie R; Troncone, Luca; Lebeche, Djamel (2018) SERCA control of cell death and survival. Cell Calcium 69:46-61
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Schloss, Jennifer; Ali, Riyasat; Racine, Jeremy J et al. (2018) HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. J Immunol 200:3353-3363
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Shu, Jun; Santulli, Gaetano (2018) Update on peripheral artery disease: Epidemiology and evidence-based facts. Atherosclerosis 275:379-381
Zhao, Xiaoping; Zhao, Li; Yang, Hao et al. (2018) Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma. J Biol Chem 293:6623-6634

Showing the most recent 10 out of 559 publications